| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACPP
|
acid phosphatase, prostate
|
|
ADA
|
adenosine deaminase
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ALB
|
albumin
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ANXA2
|
annexin A2
|
|
AP3D1
|
adaptor-related protein complex 3, delta 1 subunit
|
|
APOBEC3B
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
|
|
APOBEC3C
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APOL1
|
apolipoprotein L, 1
|
|
ATF4
|
activating transcription factor 4
|
|
B2M
|
beta-2-microglobulin
|
|
B3GAT1
|
beta-1,3-glucuronyltransferase 1
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BANP
|
BTG3 associated nuclear protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRD2
|
bromodomain containing 2
|
|
BRD4
|
bromodomain containing 4
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL28
|
chemokine (C-C motif) ligand 28
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNT1
|
cyclin T1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD163
|
CD163 molecule
|
|
CD207
|
CD207 molecule, langerin
|
|
CD209
|
CD209 molecule
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD300A
|
CD300a molecule
|
|
CD34
|
CD34 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40LG
|
CD40 ligand
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD80
|
CD80 molecule
|
|
CD8A
|
CD8a molecule
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDK9
|
cyclin-dependent kinase 9
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
|
CNOT1
|
CCR4-NOT transcription complex, subunit 1
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNR2
|
cannabinoid receptor 2 (macrophage)
|
|
COMT
|
catechol-O-methyltransferase
|
|
COX2
|
|
|
CPSF3
|
cleavage and polyadenylation specific factor 3, 73kDa
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CREBBP
|
CREB binding protein
|
|
CRLS1
|
cardiolipin synthase 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSTB
|
cystatin B (stefin B)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSK
|
cathepsin K
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP3A
|
cytochrome P450, family 3, subfamily A
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
DBN1
|
drebrin 1
|
|
DDX1
|
DEAD (Asp-Glu-Ala-Asp) box helicase 1
|
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DEFA5
|
defensin, alpha 5, Paneth cell-specific
|
|
DEFA6
|
defensin, alpha 6, Paneth cell-specific
|
|
DEFB1
|
defensin, beta 1
|
|
DEFB4A
|
defensin, beta 4A
|
|
DIAPH2
|
diaphanous-related formin 2
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DNAL1
|
dynein, axonemal, light chain 1
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRAM1
|
DNA-damage regulated autophagy modulator 1
|
|
DRD3
|
dopamine receptor D3
|
|
DYNC1I1
|
dynein, cytoplasmic 1, intermediate chain 1
|
|
EDN1
|
endothelin 1
|
|
EGR1
|
early growth response 1
|
|
EGR2
|
early growth response 2
|
|
EGR3
|
early growth response 3
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELL2
|
elongation factor, RNA polymerase II, 2
|
|
ENG
|
endoglin
|
|
EOMES
|
eomesodermin
|
|
EP300
|
E1A binding protein p300
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESR1
|
estrogen receptor 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F11R
|
F11 receptor
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FGF21
|
fibroblast growth factor 21
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FREM1
|
FRAS1 related extracellular matrix 1
|
|
FUCA1
|
fucosidase, alpha-L- 1, tissue
|
|
GH1
|
growth hormone 1
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLB1
|
galactosidase, beta 1
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GPR15
|
G protein-coupled receptor 15
|
|
GPX3
|
glutathione peroxidase 3
|
|
GTF2H4
|
general transcription factor IIH, polypeptide 4, 52kDa
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HCP5
|
HLA complex P5 (non-protein coding)
|
|
HDAC1
|
histone deacetylase 1
|
|
HEXA
|
hexosaminidase A (alpha polypeptide)
|
|
HEXB
|
hexosaminidase B (beta polypeptide)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNRNPA1
|
heterogeneous nuclear ribonucleoprotein A1
|
|
HNRNPK
|
heterogeneous nuclear ribonucleoprotein K
|
|
HNRNPR
|
heterogeneous nuclear ribonucleoprotein R
|
|
HNRNPU
|
heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)
|
|
HP
|
haptoglobin
|
|
HPBP
|
phosphate binding apolipoprotein
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSP90AB1
|
heat shock protein 90kDa alpha (cytosolic), class B member 1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFI16
|
interferon, gamma-inducible protein 16
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNG
|
interferon, gamma
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IKBKE
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon
|
|
IL10
|
interleukin 10
|
|
IL12B
|
interleukin 12B
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
IL7R
|
interleukin 7 receptor
|
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB7
|
integrin, beta 7
|
|
ITK
|
IL2-inducible T-cell kinase
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
KARS
|
lysyl-tRNA synthetase
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNMA1
|
potassium channel, calcium activated large conductance subfamily M alpha, member 1
|
|
KHDRBS1
|
KH domain containing, RNA binding, signal transduction associated 1
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIR3DS1
|
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
|
|
KLRC2
|
killer cell lectin-like receptor subfamily C, member 2
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KPNA4
|
karyopherin alpha 4 (importin alpha 3)
|
|
LARP7
|
La ribonucleoprotein domain family, member 7
|
|
LEP
|
leptin
|
|
LGALS3BP
|
lectin, galactoside-binding, soluble, 3 binding protein
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LIMS1
|
LIM and senescent cell antigen-like domains 1
|
|
LMNA
|
lamin A/C
|
|
LPA
|
lipoprotein, Lp(a)
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
MAATS1
|
MYCBP-associated, testis expressed 1
|
|
MAN1A1
|
mannosidase, alpha, class 1A, member 1
|
|
MAP4
|
microtubule-associated protein 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPT
|
microtubule-associated protein tau
|
|
MB21D1
|
Mab-21 domain containing 1
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR148A
|
microRNA 148a
|
|
MIR21
|
microRNA 21
|
|
MKL2
|
MKL/myocardin-like 2
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MRC1
|
mannose receptor, C type 1
|
|
MRC2
|
mannose receptor, C type 2
|
|
MSN
|
moesin
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTDH
|
metadherin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC5B
|
mucin 5B, oligomeric mucus/gel-forming
|
|
MUC7
|
mucin 7, secreted
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MYBPC1
|
myosin binding protein C, slow type
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
NCOR2
|
nuclear receptor corepressor 2
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NELFE
|
negative elongation factor complex member E
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NMT1
|
N-myristoyltransferase 1
|
|
NMT2
|
N-myristoyltransferase 2
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPC2
|
Niemann-Pick disease, type C2
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NSMF
|
NMDA receptor synaptonuclear signaling and neuronal migration factor
|
|
NT5E
|
5'-nucleotidase, ecto (CD73)
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
NUP98
|
nucleoporin 98kDa
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PANX1
|
pannexin 1
|
|
PARD3B
|
par-3 family cell polarity regulator beta
|
|
PDCD1
|
programmed cell death 1
|
|
PDYN
|
prodynorphin
|
|
PHB
|
prohibitin
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PSMD7
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 7
|
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTMA
|
prothymosin, alpha
|
|
PTN
|
pleiotrophin
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
RAB4A
|
RAB4A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RNF125
|
ring finger protein 125, E3 ubiquitin protein ligase
|
|
RNF2
|
ring finger protein 2
|
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
ROBO4
|
roundabout, axon guidance receptor, homolog 4 (Drosophila)
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RXRG
|
retinoid X receptor, gamma
|
|
SAA1
|
serum amyloid A1
|
|
SAMHD1
|
SAM domain and HD domain 1
|
|
SDC2
|
syndecan 2
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SEMG1
|
semenogelin I
|
|
SEMG2
|
semenogelin II
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SETD7
|
SET domain containing (lysine methyltransferase) 7
|
|
SFTPD
|
surfactant protein D
|
|
SH3RF1
|
SH3 domain containing ring finger 1
|
|
SIRT1
|
sirtuin 1
|
|
SLC11A1
|
solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SMARCD3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
|
|
SNAP23
|
synaptosomal-associated protein, 23kDa
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SP1
|
Sp1 transcription factor
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SST
|
somatostatin
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
SYK
|
spleen tyrosine kinase
|
|
TAC1
|
tachykinin, precursor 1
|
|
TARBP2
|
TAR (HIV-1) RNA binding protein 2
|
|
TBC1D20
|
TBC1 domain family, member 20
|
|
TBX21
|
T-box 21
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TFRC
|
transferrin receptor
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
THPO
|
thrombopoietin
|
|
THY1
|
Thy-1 cell surface antigen
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TMED1
|
transmembrane emp24 protein transport domain containing 1
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF18
|
tumor necrosis factor receptor superfamily, member 18
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNPO3
|
transportin 3
|
|
TP53
|
tumor protein p53
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TREX1
|
three prime repair exonuclease 1
|
|
TRIM25
|
tripartite motif containing 25
|
|
TRIM5
|
tripartite motif containing 5
|
|
UBD
|
ubiquitin D
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VPRBP
|
Vpr (HIV-1) binding protein
|
|
WASF2
|
WAS protein family, member 2
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WFDC1
|
WAP four-disulfide core domain 1
|
|
XDH
|
xanthine dehydrogenase
|
|
XPO1
|
exportin 1
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZC3H15
|
zinc finger CCCH-type containing 15
|
|
ZNRD1
|
zinc ribbon domain containing 1
|